Effects of an Intervention Program by Proprioceptive Neuromuscular Facilitation, in Muscle Force Irradiation.
Electromyography Evaluation of the Stabilizing Muscles of the Scapula and Tibial Anterior Muscle, After an Intervention Program by Proprioceptive Neuromuscular Facilitation in Muscle Force Irradiation.
1 other identifier
interventional
120
1 country
1
Brief Summary
The present study aims to assess through surface electromyography, the effectiveness of proprioceptive neuromuscular facilitation protocols in the activation of the stabilizing muscles of the scapula and the anterior tibial muscle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 23, 2014
CompletedFirst Posted
Study publicly available on registry
October 2, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedOctober 2, 2014
September 1, 2014
1.1 years
September 23, 2014
September 29, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of muscle force irradiation, through surface electromyography.
Irradiation of muscle strength will be assessed using surface electromyography, which shows the activation or not of the muscles evaluated.
This evaluation of patients is performed in only one day, being made before, during and after the application of the protocols. It is estimated that the results are collected in one years.
Study Arms (2)
Healthy group.
OTHERGroup formed by healthy patients.
Group with demyelinating polyneuropathy
OTHERGroup formed by patients with demyelinating polyneuropathy.
Interventions
Eligibility Criteria
You may qualify if:
- Healthy individuals group: who agree to participate in the study with no history of previous trauma or disease of the shoulder girdle, with absence of clinical signs painful in the shoulder joint.
- Group with demyelinating polyneuropathy: both sexes, carriers of CMT-1A disease with functional changes in the lower limbs with good cognition and difficulty of to ambulate with and without assistance.
You may not qualify if:
- Healthy individuals group: subject with restricted range of motion, muscle weakness, cognitive impairment, which exhibits a pathology that leads to alterations in muscle recruitment.
- Patients with polyneuropathy: cardiac arrhythmias, uncontrolled hypertension, severe cardiovascular disease and respiratory problems. The use of own medicines to treat pathology was accepted.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laboratory of Neuropsychobiology and Motor Behavior,
Ribeirão Preto, São Paulo, Brazil
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ana Cláudia Silva Ferreira
Study Record Dates
First Submitted
September 23, 2014
First Posted
October 2, 2014
Study Start
July 1, 2014
Primary Completion
August 1, 2015
Last Updated
October 2, 2014
Record last verified: 2014-09